Screening for TP53 rearrangements in families with the Li–Fraumeni syndrome reveals a complete deletion of the TP53 gene

被引:0
|
作者
Gaëlle Bougeard
Laurence Brugières
Agnès Chompret
Paul Gesta
Françoise Charbonnier
Alexander Valent
Cosette Martin
Grégory Raux
Jean Feunteun
Brigitte Bressac-de Paillerets
Thierry Frébourg
机构
[1] Inserm EMI 9906 – IFRMP,Department of Pediatrics
[2] Faculty of Medicine,Department of Genetics
[3] Institut Gustave Roussy,Department of Cellular Genomics of Cancers
[4] Oncology,Department of Clinical Biology
[5] Centre Hospitalier,undefined
[6] CHU of Rouen,undefined
[7] Institut Gustave Roussy,undefined
[8] UMR 8125,undefined
[9] Institut Gustave Roussy,undefined
[10] Institut Gustave Roussy,undefined
来源
Oncogene | 2003年 / 22卷
关键词
Li–Fraumeni syndrome; deletion; PCR;
D O I
暂无
中图分类号
学科分类号
摘要
The absence of detectable germline TP53 mutations in a fraction of families with Li–Fraumeni syndrome (LFS) has suggested the involvement of other genes, but this hypothesis remains controversial. The density of Alu repeats within the TP53 gene led us to search genomic rearrangements of TP53 in families without detectable TP53 mutation. To this aim, we adapted the quantitative multiplex PCR of short fluorescent fragments (QMPSF) method to the analysis of the 11 exons of TP53. We analysed 98 families, either fulfilling (six families) or partially meeting (92 families) the criteria for LFS, and in which classical methods had failed to reveal TP53 alterations. We identified, in a large family fulfilling the criteria for LFS, a complete heterozygous deletion of TP53. Additional QMPSF analyses indicated that this deletion, which partially removed the centromeric FLJ10385 locus, covered approximately 45 kb. This deletion was shown to result from a complex rearrangement involving two distinct Alu-mediated recombinations. We conclude that TP53 germline rearrangements occur as rare events, but must be considered in LFS families without detectable point TP53 mutation.
引用
收藏
页码:840 / 846
页数:6
相关论文
共 50 条
  • [21] Significance of intron 6 sequence variations in the TP53 gene in Li-Fraumeni syndrome
    Varley, JM
    McGown, G
    Thorncroft, M
    Kelsey, AM
    Birch, JM
    CANCER GENETICS AND CYTOGENETICS, 2001, 129 (01) : 85 - 87
  • [22] TP53 and CDKN1A mutation analysis in families with Li–Fraumeni and Li–Fraumeni like syndromes
    Raissa Coelho Andrade
    Anna Claudia Evangelista dos Santos
    Joaquim Caetano de Aguirre Neto
    Julián Nevado
    Pablo Lapunzina
    Fernando Regla Vargas
    Familial Cancer, 2017, 16 : 243 - 248
  • [23] Estimating TP53 Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPRO
    Peng, Gang
    Bojadzieva, Jasmina
    Ballinger, Mandy L.
    Li, Jialu
    Blackford, Amanda L.
    Mai, Phuong L.
    Savage, Sharon A.
    Thomas, David M.
    Strong, Louise C.
    Wang, Wenyi
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (06) : 837 - 844
  • [24] Chromosome instability in fibroblasts derived from Li–Fraumeni syndrome families without TP53 mutations
    J M Boyle
    A Spreadborough
    M J Greaves
    J M Birch
    D Scott
    British Journal of Cancer, 2000, 83 : 1136 - 1138
  • [25] Screening newborns for TP53
    Zlotogora, Joel
    LANCET ONCOLOGY, 2009, 10 (12): : 1142 - 1142
  • [26] New surveillance guidelines for Li-Fraumeni and hereditary TP53 related cancer syndrome: implications for germline TP53 testing in breast cancer
    Evans, D. Gareth
    Woodward, Emma R.
    FAMILIAL CANCER, 2021, 20 (01) : 1 - 7
  • [27] New surveillance guidelines for Li-Fraumeni and hereditary TP53 related cancer syndrome: implications for germline TP53 testing in breast cancer
    D. Gareth Evans
    Emma R. Woodward
    Familial Cancer, 2021, 20 : 1 - 7
  • [28] Contribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndrome
    Renaux-Petel, Mariette
    Charbonnier, Francoise
    Thery, Jean-Christophe
    Fermey, Pierre
    Lienard, Gwendoline
    Bou, Jacqueline
    Coutant, Sophie
    Vezain, Myriam
    Kasper, Edwige
    Fourneaux, Steeve
    Manase, Sandrine
    Blanluet, Maud
    Leheup, Bruno
    Mansuy, Ludovic
    Champigneulle, Jacqueline
    Chappe, Celine
    Longy, Michel
    Sevenet, Nicolas
    Bressac-de Paillerets, Brigitte
    Guerrini-Rousseau, Lea
    Brugieres, Laurence
    Caron, Olivier
    Sabourin, Jean-Christophe
    Tournier, Isabelle
    Baert-Desurmont, Stephanie
    Frebourg, Thierry
    Bougeard, Gaelle
    JOURNAL OF MEDICAL GENETICS, 2018, 55 (03) : 173 - 180
  • [29] Two TP53 germline mutations in a classical Li-Fraumeni syndrome family
    van Hest, Liselotte P.
    Ruijs, Marielle W. G.
    Wagner, Anja
    van der Meer, Conny A.
    Verhoef, Senno
    van't Veer, Laura J.
    Meijers-Heijboer, Hanne
    FAMILIAL CANCER, 2007, 6 (03) : 311 - 316
  • [30] Germline tp53 neomutation in a patient with Li-Fraumeni syndrome, and pancreatic adenocarcinoma
    Lefrou, L
    Godart, B
    de Muret, A
    Scotto, B
    Dorval, E
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2006, 30 (03): : 484 - 486